Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Critical thinking about serious infections: Case based reasoning to optimize management


To register for and complete this program, please visit criticalthinkingcme.com!
 
 
 
Privacy and Confidentiality:  Information received by the University of South Carolina College of Pharmacy for continuing education (CE) programs will be maintained in a confidential and secure manner.  In order for continuing education credit to be submitted to the NABP CPE Monitor, personal information such as your NABP e-Profile ID and day and month of birth will be required along with your name and contact information.
 
Provider Contact Information:  For questions regarding this continuing education activity, please contact our office at CE@cop.sc.edu or 803-777-9979.

Fee

$0.00

CE Hours

3.00

CE Units

0.300

Activity Type

  • Application

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Context Healthcare Group, University of Cincinnati

Requirements for CE Credit

In order to have continuing pharmacy education credit submitted to the NABP CPE Monitor, participants must complete the modules, post-tests, and evaluations through the Context platform before completing the pharmacist-specific evaluation on our website.  In order to complete the evaluation, you must create an account and specify your correct NABP e-Profile ID and day/month of birth.  Once this pharmacist-specific evaluation has been completed, credit will be submitted to the NABP CPE Monitor.  We request that the pharmacist-specific evaluation be completed within 30 days in order for us to ensure your credit is transmitted to the NABP CPE Monitor.  Any credit claimed more than 60 days after completion of the program will be automatically rejected by the NABP CPE Monitor.
 
To create an NABP e-Profile ID or verify your NABP e-Profile ID, please click on the link below: 

 

 

 

At the completion of this activity, the participant will be able to:
1. List risk factors associated with cytomegalovirus (CMV) reactivation in hematopoietic cell and solid organ transplantation recipients
2. Compare prophylactic and pre-emptive CMV management strategies
3. Describe currently available and investigational therapeutic options for preventing cytomegalovirus infections

Speaker(s)/Author(s)

Camille Kotton, MD
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases; Infectious Diseases Division, Massachusetts General Hospital; Harvard Medical Sc

Keith Kaye, MD
Professor of Internal Medicine; Director of Clinical Research, Division of Infectious Diseases, University of Michigan Medical School

Roy Chemaly, MD
Professor of Medicine; Director, Infection Control Section; Director of Clinical Virology; Department of ID/IC/EH, UT MD Anderson Cancer Center

Activity Number

0062-9999-18-036-H01-P

Release Date: Mar 1, 2018
Credit Expiration Date: Feb 28, 2019

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
1. List risk factors associated with cytomegalovirus (CMV) disease in hematopoietic cell and solid organ
transplantation recipients
2. Recognize the impact of drug-resistant CMV infections on patient outcomes
3. Differentiate currently available and investigational therapeutic options for treating CMV infections

Speaker(s)/Author(s)

Camille Kotton, MD
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases; Infectious Diseases Division, Massachusetts General Hospital; Harvard Medical Sc

Keith Kaye, MD
Professor of Internal Medicine; Director of Clinical Research, Division of Infectious Diseases, University of Michigan Medical School

Roy Chemaly, MD
Professor of Medicine; Director, Infection Control Section; Director of Clinical Virology; Department of ID/IC/EH, UT MD Anderson Cancer Center

Activity Number

0062-9999-18-037-H01-P

Release Date: Mar 1, 2018
Credit Expiration Date: Feb 28, 2019

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
1. List risk factors associated with multi-drug-resistant (MDR) gram-negative bacterial (GNB) infections
2. Describe best practices for the antibiotic treatment of MDR GNB infections
3. Evaluate new and investigational options for the antibiotic treatment of MDR GNB infections

Speaker(s)/Author(s)

Camille Kotton, MD
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases; Infectious Diseases Division, Massachusetts General Hospital; Harvard Medical Sc

Keith Kaye, MD
Professor of Internal Medicine; Director of Clinical Research, Division of Infectious Diseases, University of Michigan Medical School

Roy Chemaly, MD
Professor of Medicine; Director, Infection Control Section; Director of Clinical Virology; Department of ID/IC/EH, UT MD Anderson Cancer Center

Activity Number

0062-9999-18-038-H01-P

Release Date: Mar 1, 2018
Credit Expiration Date: Feb 28, 2018

CE Hours

1.00